9 Heart Failure Clinical Trials in Fairhope, AL (2026)

Q: How do I join a clinical trial in Fairhope?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Fairhope research site will contact you.

Recruiting Heart Failure Studies in Fairhope

NCT06677060Recruiting

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Participants include men and women ≥ 40 years of age with T2DM, established CV disease, a history of HTN with an SBP of at least 130 mmHg at screening, who meet the predefined serum potassium level, a...

Fairhope, ALPHASE311,300 participantsAstraZeneca

View Study Details

NCT06008197Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients hospitalized with acute decompensated heart failure (HF) and mildly reduced or preserved left ventricul...

Fairhope, ALPHASE35,200 participantsColorado Prevention Center

View Study Details

NCT07037459Recruiting

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

This study will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascu...

Fairhope, ALPHASE35,056 participantsAmgen

View Study Details

NCT06307652Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney function...

Fairhope, ALPHASE34,800 participantsAstraZeneca

View Study Details

NCT06033950Recruiting

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists

Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients with heart failure and reduced ejection fraction (HFrEF) who are intolerant or ineligible to receive tr...

Fairhope, ALPHASE32,600 participantsColorado Prevention Center

View Study Details

NCT06024746Recruiting

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)

Combination therapy of finerenone plus empagliflozin will be compared to usual care to determine the efficacy and safety of treatment in patients hospitalized with heart failure....

Fairhope, ALPHASE31,500 participantsColorado Prevention Center

View Study Details

NCT06200207Recruiting

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation

The study is being done to see if ziltivekimab can be used to treat participants living with heart failure and inflammation. Participants will either get ziltivekimab (active medicine) or placebo (ina...

Fairhope, ALPHASE3680 participantsNovo Nordisk A/S

View Study Details

NCT06378632Recruiting

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

Study Design: This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively ...

Fairhope, AL500 participantsCordio Medical

View Study Details

NCT06793371Recruiting

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

This is a Phase 2 dose-finding study in adult participants with symptomatic HFpEF....

Fairhope, ALPHASE260 participantsCytokinetics

View Study Details

About Heart Failure Clinical Trials in Fairhope

Heart failure is a chronic condition where the heart cannot pump blood efficiently to meet the body's needs. It affects millions of people worldwide and can result from various heart conditions. Treatment includes medications, lifestyle changes, devices, and in severe cases, heart transplant.

There are currently 9 heart failure clinical trials recruiting participants in Fairhope, AL. These studies are seeking a combined 31,696 participants. Research is being sponsored by AstraZeneca, Colorado Prevention Center, Amgen and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Failure Clinical Trials in Fairhope — FAQ

Are there heart failure clinical trials in Fairhope?

Yes, there are 9 heart failure clinical trials currently recruiting in Fairhope, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fairhope?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fairhope research site will contact you about next steps.

Are clinical trials in Fairhope free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fairhope studies also compensate for your time and travel.

What heart failure treatments are being tested?

The 9 active trials in Fairhope are testing new therapies including novel drugs, biologics, and treatment approaches for heart failure.

Data updated July 22, 2026 from ClinicalTrials.gov